Search Results for 'monoclonal antibodies'

---

Contract Service Directory Companies

View All Buyers Guide Companies »

---

• Althea Announces Issuance of New US Patent for Manufacturing of Crystal Monoclonal Antibodies

  SAN DIEGO, CA, May 17, 2016 — Ajinomoto Althea Inc., a leading provider of biotherapeutic contract development and manufacturing services, today announced that the United States Patent and Trademark Office has issued US Patent 9,310,379 cove…

  ---

• Bio News | Breaking News | Industry News

  Ajinomoto Althea Receives Patent for Manufacturing Crystal Monoclonal Antibodies

  Methods aid stabilization, storage and delivery of biologically active antibody crystals

  05.17.16
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Drug Development | Formulation Development | Process Development

  Goodwin Biotechnology Completes cGMP Manufacturing of an IgM Monoclonal Antibody

  Successful clearance of Q Therapeutics' IND submission for Q-Cells cell therapy in ALS

  07.17.15
  

  ---

• Biosimilars | Clinical Trials

  Indian Generics Expand in mAbs

  As they focus on generic biologics, Indian firms are setting their sights on monoclonal antibodies

  S. Harachand, Contributing Editor 07.21.14
  

  ---

• Biosimilars | cGMP Manufacture | Toxicology

  Too Much CMO Capacity?

  A decade ago, there were dire concerns that the biopharmaceutical industry was headed for a severe crisis. There was, it was thought, inadequate mammalian manufacturing capacity to support the development pipeline. In particular, fears grew about sho…

  Eric A. Langer, BioPlan Associates 03.07.14
  

  ---

• Aseptic Processing | Biologics, Proteins, Vaccines | Breaking News | Capsules | Clinical Trial Materials | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Lyophilization | Methods Development | Parenterals | Process Development | QA/QC | Regulatory Affairs | Scale-up/Technology Transfer | Toxicology | Validation | Vials

  Kemwell Signs Monoclonal Antibody Pact

  Expects European inspection within year

  Gil Roth 09.18.13
  

  ---

• Process Development | Validation
  

  Upstream Processes for Monoclonal Antibodies

  The importance of media selection and scale-down models for development

  Dominique Buteux, Aurore Lahille, Sebastien Ribault, Merck Millipore 09.05.13
  

  ---

• Chemistry | Clinical Trials | Excipients | Formulation Development | Process Development | Toxicology | Validation | Vials
  

  CMC Activities for Development of MAbs

  Critical steps to reach IND with a therapeutic antibody

  Susan Dana Jones, Patricia Seymour and Howard L. Levine 04.05.10
  

  ---